DF/HCC Celebration of Early Career Investigators in Cancer Research
Early career investigators are a unique reservoir of new ideas, innovation, and excellence in cancer research. To celebrate this, we welcome you to join the 12th Annual DF/HCC Celebration of Early Investigators in Cancer Research. This symposium will showcase the talent of early career investigators at the Dana-Farber/Harvard Cancer Center (DF/HCC) who work in several areas of population science, including epidemiology, biostatistics, outcomes, diversity, and survivorship. We invite all members of the public to attend the event. We also invite students, post-docs, residents, clinical fellows, and early career investigators to submit abstracts for consideration as oral or poster presentations. We look forward to an exciting afternoon of discussion, sharing new discoveries, and building new collaborations. – Lorelei Mucci, ScD (HSPH), Giovanni Parmigiani, PhD (DFCI), Erica Feick (DFCI), Hannah Guard (HSPH), and Megan Shanahan (HSPH).
This event will be held at Dana-Farber Cancer Institute in the Yawkey Conference Center. Currently, the event will be held in-person; however, adjustments to the event status will be considered if there are changes to masking regulations.
2024 Award Winners
Best Oral Presentation:
Noah Chigier (DFCI) and Brett Ranieri (DFCI)
Most Innovative Idea:
Phillip Nicol (HU)
Best Poster Presentation:
Kelcie Willis (MGH)
2024 Agenda
DECEMBER 3, 2024
1:00 – 1:10 pm | Welcome and Introductions Ramesh Shivdasani, MD, PhD, Deputy Director of the DF/HCC Lorelei A. Mucci, ScD, MPH, Deputy Associate Director of the Population Science Programs at the DF/HCC Brittany M. Charlton, ScD, Co-leader of the Cancer Epidemiology Program at the DF/HCC |
1:10 – 2:00 pm | Keynote Speaker Scout, Ph.D., M.A. Talk Title: When Your Career Is Both Your Passion Project & A Political Football Abstract: I completed my PhD in Sociomedical Sciences with a concentration on LGBTQI+ health right as we changed over from one of the most welcoming presidential administrations to one of the most hostile on this topic to date - things were looking grim about my professional prospects. Perhaps because of this I moved into using my and other people's research to forward policy advocacy for my communities. En route to today I learned a lot about how policy is usually shaped by the experts in our field, experts like yourselves; how to poke the head of NIH enough until he starts asking you to serve; and the power of ghostwriting to change the world. Much of this work is necessarily very quiet, since the best policy moves leave someone else thinking they had the good idea. So come learn how scientists and clinicians are needed on the advocacy landscape and how you can multiply your community impact regardless of who's using your passion project as a political football. |
2:00 – 2:45 pm | Oral Presentation (part 1) Cong Wang, PhD, MPH: Inflammatory proteomic signatures of metabolically unhealthy obesity Ava Kikut-Stein, PhD: A community based participatory research approach to promoting equity in adolescent and young adult cancer communication Sarah Piombo, PhD, MPH: The impact of community connectedness on tobacco refusal skills among youth in India from low socio-economic backgrounds Noah Chigier, BKin and Brett Ranieri, BA: Impact of fatigue and sleep quality on exercise adherence among Latina and/or Hispanic breast cancer survivors |
2:45 – 3:00 pm | Break |
3:00 – 3:45 | Oral Presentation (part 2) LeeAnn Lucas, MS: Early-life risk factors and higher-grade prostate cancer Phillip Nicol, MA: Phylogeographic-based estimation of tumor cell motility from spatially resolved single-cell sequencing data Yuliya Leontyeva, PhD: Selection bias built into hazard ratios – an empirical demonstration in a large precision oncology trial Carmen Rodriguez Cabrera, AM, MPH: A Bayesian mixture model approach to examining neighborhood social determinants of health disparities in endometrial cancer treatment in Massachusetts Yoshitaka Nishikawa, MD, PhD: Thyroid screening outcomes and stable iodine intake among children after the 2011 Fukushima Nuclear Power Plant accident in Japan. |
3:45 – 5:00 pm | Poster Session and Reception Hanan Abdelrahman, PhD: Symptoms prevalence and quality of life among cancer survivors in Oman Mina Bakhtiar, MD: Substance use, cancer incidence, and mortality among Medicare beneficiaries Shweta Gupta, PhD: Exosome-mediated smart and targeted drug delivery for cancer theranostics Nan Lin, PhD: The role of distress-related metabolic dysfunction in ovarian cancer development Jennifer Mongiovi, PhD, MS: Contraception and ovarian cancer tumor immune profiles Patrick Ryan, PhD: ATG4B is an oncogene in lung adenocarcinoma Koki Takabatake, MPH: Age-specific risk of ovarian cancer in families with PALB2 |
5:00 pm | Award Announcement Best Oral Presentation Most Innovative Idea Best Poster Presentation |